Noninvasive diagnostic strategies for peripheral arterial disease

Article Type
Article
Changed
Display Headline
Noninvasive diagnostic strategies for peripheral arterial disease
Author(s)
Susan M. Begelman, MD
Michael R. Jaff, DO
Article PDF
content_73_Suppl_4_SI-22.pdf
Author and Disclosure Information

Susan M. Begelman, MD
Nuvelo, Inc., San Carlos, CA

Michael R. Jaff, DO
Harvard Medical School and Massachusetts General Hospital, Boston, MA

Correspondence: Susan M. Begelman, MD, FACC, Associate Director, Clinical Sciences/Cardiovascular, Nuvelo, Inc., 201 Industrial Road, Suite 310, San Carlos, CA 94070–6211; sbegelman@nuvelo.com

Dr. Begelman reported that she has no financial relationships that pose a potential conflict of interest with this article.

Dr. Jaff reported that he has received honoraria for teaching and speaking from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

At the time this article was written, Dr. Begelman was employed in the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.

Publications
Cleveland Clinic Journal of Medicine
Page Number
S22-S29
Author(s)
Susan M. Begelman, MD
Michael R. Jaff, DO
Author(s)
Susan M. Begelman, MD
Michael R. Jaff, DO
Author and Disclosure Information

Susan M. Begelman, MD
Nuvelo, Inc., San Carlos, CA

Michael R. Jaff, DO
Harvard Medical School and Massachusetts General Hospital, Boston, MA

Correspondence: Susan M. Begelman, MD, FACC, Associate Director, Clinical Sciences/Cardiovascular, Nuvelo, Inc., 201 Industrial Road, Suite 310, San Carlos, CA 94070–6211; sbegelman@nuvelo.com

Dr. Begelman reported that she has no financial relationships that pose a potential conflict of interest with this article.

Dr. Jaff reported that he has received honoraria for teaching and speaking from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

At the time this article was written, Dr. Begelman was employed in the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.

Author and Disclosure Information

Susan M. Begelman, MD
Nuvelo, Inc., San Carlos, CA

Michael R. Jaff, DO
Harvard Medical School and Massachusetts General Hospital, Boston, MA

Correspondence: Susan M. Begelman, MD, FACC, Associate Director, Clinical Sciences/Cardiovascular, Nuvelo, Inc., 201 Industrial Road, Suite 310, San Carlos, CA 94070–6211; sbegelman@nuvelo.com

Dr. Begelman reported that she has no financial relationships that pose a potential conflict of interest with this article.

Dr. Jaff reported that he has received honoraria for teaching and speaking from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

At the time this article was written, Dr. Begelman was employed in the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.

Article PDF
content_73_Suppl_4_SI-22.pdf
Article PDF
content_73_Suppl_4_SI-22.pdf
Page Number
S22-S29
Page Number
S22-S29
Publications
Cleveland Clinic Journal of Medicine
Publications
Cleveland Clinic Journal of Medicine
Article Type
Article
Display Headline
Noninvasive diagnostic strategies for peripheral arterial disease
Display Headline
Noninvasive diagnostic strategies for peripheral arterial disease
Citation Override
Cleveland Clinic Journal of Medicine 2006 October;73(suppl 4):S22-S29
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media

Heparin-induced thrombocytopenia: Principles for early recognition and management

Article Type
Article
Changed
Display Headline
Heparin-induced thrombocytopenia: Principles for early recognition and management
Author(s)
John R. Bartholomew, MD
Susan M. Begelman, MD
Amjad AlMahameed, MD, MPH, FACP
Article PDF
content_72_Suppl_1_SI-31.pdf
Author and Disclosure Information

John R. Bartholomew, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine and the Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, Ohio

Susan M. Begelman, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Amjad AlMahameed, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: John R. Bartholomew, MD, Section of Vascular Medicine, S60, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; barthoj@ccf.org

Dr. Bartholomew is a consultant for The Medicines Company and on the speakers' bureau of GlaxoSmithKline.

Dr. Begelman is a consultant for and on the speakers' bureau of GlaxoSmithKline.

Dr. AlMahameed has indicated that he has nothing to disclose.

Publications
Cleveland Clinic Journal of Medicine
Page Number
S31-S36
Author(s)
John R. Bartholomew, MD
Susan M. Begelman, MD
Amjad AlMahameed, MD, MPH, FACP
Author(s)
John R. Bartholomew, MD
Susan M. Begelman, MD
Amjad AlMahameed, MD, MPH, FACP
Author and Disclosure Information

John R. Bartholomew, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine and the Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, Ohio

Susan M. Begelman, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Amjad AlMahameed, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: John R. Bartholomew, MD, Section of Vascular Medicine, S60, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; barthoj@ccf.org

Dr. Bartholomew is a consultant for The Medicines Company and on the speakers' bureau of GlaxoSmithKline.

Dr. Begelman is a consultant for and on the speakers' bureau of GlaxoSmithKline.

Dr. AlMahameed has indicated that he has nothing to disclose.

Author and Disclosure Information

John R. Bartholomew, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine and the Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, Ohio

Susan M. Begelman, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Amjad AlMahameed, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio

Correspondence: John R. Bartholomew, MD, Section of Vascular Medicine, S60, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; barthoj@ccf.org

Dr. Bartholomew is a consultant for The Medicines Company and on the speakers' bureau of GlaxoSmithKline.

Dr. Begelman is a consultant for and on the speakers' bureau of GlaxoSmithKline.

Dr. AlMahameed has indicated that he has nothing to disclose.

Article PDF
content_72_Suppl_1_SI-31.pdf
Article PDF
content_72_Suppl_1_SI-31.pdf
Page Number
S31-S36
Page Number
S31-S36
Publications
Cleveland Clinic Journal of Medicine
Publications
Cleveland Clinic Journal of Medicine
Article Type
Article
Display Headline
Heparin-induced thrombocytopenia: Principles for early recognition and management
Display Headline
Heparin-induced thrombocytopenia: Principles for early recognition and management
Citation Override
Cleveland Clinic Journal of Medicine 2005 April;72(suppl 1):S31-S36
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media
Subscribe to Susan M. Begelman, MD